Pay in 4 interest-free payments of $7.44 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
All parcels will be delivered to the provided address and will require a signature on receipt, It is recommended to provide a work address for delivery if no one is home during business hours
First, inflammation must be controlled
Research Focus Areas Investigations into copper transport and biological copper homeostasis Studies of dermal fibroblast collagen and elastin synthesis in cell culture Examination of wound-healing pathways in rodent skin models Antioxidant and superoxide-dismutase mimetic activity in in-vitro assays Hair-follicle and dermal-papilla cell research Quality & Verification Synthesized via solid-phase peptide synthesis (SPPS) in an ISO-certified facility 99% purity verified by reverse-phase HPLC Cu content confirmed by atomic absorption spectroscopy or ICP-MS Independent third-party Certificate of Analysis available on request Sequence: Gly-His-Lys (with Cu coordination) Storage & Handling Store lyophilized vials at 20C for long-term stability (protected from light) Once reconstituted, store at 28C and use within 2830 days Avoid repeated freeze-thaw cycles Sealed under nitrogen and shipped in insulated packaging Preclinical Research Summary GHK-Cu is the copper(II) complex of the endogenous human tripeptide glycyl-L-histidyl-L-lysine (Gly-His-Lys)
It has not undergone Phase I, II, or III human clinical trials and is not recognized as Generally Recognized as Safe (GRAS)
Dihexa crosses the blood-brain barrier and demonstrates oral bioavailability, properties that are rare among cognitive-enhancing peptides
Common mild side effects include red urine, soreness at the injection site, or a mild rash
